R. Medori

2.0k total citations
45 papers, 1.5k citations indexed

About

R. Medori is a scholar working on Psychiatry and Mental health, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, R. Medori has authored 45 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Psychiatry and Mental health, 13 papers in Molecular Biology and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in R. Medori's work include Schizophrenia research and treatment (10 papers), Muscle Physiology and Disorders (6 papers) and Mitochondrial Function and Pathology (4 papers). R. Medori is often cited by papers focused on Schizophrenia research and treatment (10 papers), Muscle Physiology and Disorders (6 papers) and Mitochondrial Function and Pathology (4 papers). R. Medori collaborates with scholars based in Italy, United States and Germany. R. Medori's co-authors include Pierluigi Gambetti, E Lugaresi, P. Montagna, L. Autilio‐Gambetti, Pietro Cortelli, Paolo Tinuper, Salvatore Monaco, Leisl Packer, Agostino Baruzzi and R. Gallassi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Neuroscience and Neurology.

In The Last Decade

R. Medori

42 papers receiving 1.4k citations

Peers

Countries citing papers authored by R. Medori

Since Specialization

Citations

This map shows the geographic impact of R. Medori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Medori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Medori more than expected).

Fields of papers citing papers by R. Medori

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Medori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Medori. The network helps show where R. Medori may publish in the future.

Co-authorship network of co-authors of R. Medori

This figure shows the co-authorship network connecting the top 25 collaborators of R. Medori. A scholar is included among the top collaborators of R. Medori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Medori. R. Medori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Serum IL-17F does not predict poor response to IM IFNβ-1a in relapsing-remitting MS 2012 ·Neurology ·(unknown), Zhao Zhi-gang, Christopher Stebbins, Diego Cadavid, Alex Buko, Eric T. Whalley, John A. Davis, Eve Versage, J Richert, Robert C. Axtell, Lawrence Steinman, R. Medori	48
2	Long-term remission in schizophrenia and related psychoses with long-acting risperidone: Results obtained in an open-label study with an observation period of 18 months 2008 ·International Journal of Clinical Pharmacology and Therapeutics ·PM Llorca, (unknown), Keith Lloyd, Werner Kissling, R. Medori	30
3	Switching to Long-Acting Injectable Risperidone is Beneficial with Regard to Clinical Outcomes, Regardless of Previous Conventional Medication in Patients with Schizophrenia 2007 ·Pharmacopsychiatry ·(unknown), (unknown), (unknown), (unknown), Ricardo Teijeiro, (unknown), Muhammad Latif, R. Medori	46
4	Long-acting risperidone improves negative symptoms in stable psychotic patients 2007 ·European Psychiatry ·Vivienne Curtis, (unknown), H.–J. Moeller, R. Medori, Emilio Sacchetti	0
5	12-month efficacy and safety of OROS® MPH in children and adolescents with attention-deficit/hyperactivity disorder switched from MPH 2005 ·European Child & Adolescent Psychiatry ·Peter Hoare, Helmut Remschmidt, R. Medori, Christine Ettrich, Aribert Rothenberger, Paramala Santosh, (unknown), (unknown), (unknown), Margaret Thompson, (unknown), G.-E. Trott	32
6	Symptom control in children and adolescents with attention-deficit/hyperactivity disorder on switching from immediate-release MPH to OROS® MPH 2005 ·European Child & Adolescent Psychiatry ·Helmut Remschmidt, P. Hoare, Christine Ettrich, Aribert Rothenberger, Paramala Santosh, Martin H. Schmidt, (unknown), (unknown), Margaret Thompson, (unknown), G.-E. Trott, R. Medori	27
7	Patients in the early phases of schizophrenia and schizoaffective disorders effectively treated with risperidone long-acting injectable 2005 ·Journal of Psychopharmacology ·Eduard Parellada, (unknown), Vihra Milanova, (unknown), Marek Masiak, (unknown), R. Medori, Wolfgang Gäebel	55
8	Switching to aripiprazole monotherapy 2002 ·European Neuropsychopharmacology ·R. Medori, (unknown), (unknown), (unknown), Eveline O. Stock, Г. Ингенито	13
9	Dystrophin and its isoforms in a sympathetic ganglion of normal and dystrophic mdx mice: immunolocalization by electron microscopy and biochemical characterization 1997 ·Neuroscience ·Maria Egle De Stefano, Maria Letizia Zaccaria, (unknown), Tamara C. Petrucci, R. Medori, Paola Paggi	23
10	Lipoic (thioctic) acid increases brain energy availability and skeletal muscle performance as shown by in vivo31P-MRS in a patient with mitochondrial cytopathy 1995 ·Journal of Neurology ·Bruno Barbiroli, R. Medori, Hans Tritschler, Thomas Klopstock, Peter Seibel, Heinz Reichmann, Stefano Iotti, Raffaele Lodi, P. Zaniol	39
11	Dystrophinopathy in two young boys with exercise-induced cramps and myoglobinuria 1993 ·European Journal of Pediatrics ·Carlo Minetti, Kurenai Tanji, Hai Won Chang, R. Medori, G Cordone, S. DiMauro, E. Bonilla	23
12	Dystrophin deficiency in a case of congenital myopathy 1992 ·Journal of Neurology ·A. Prelle, R. Medori, Maurizio Moggio, (unknown), A. Gallanti, G. Scarlato, E. Bonilla	13
13	Fatal familial insomnia 1992 ·Neurology ·R. Medori, P. Montagna, (unknown), Andréa C. LeBlanc, Pietro Cortelli, Paolo Tinuper, E Lugaresi, Pierluigi Gambetti	144
14	Production of single-stranded DNA for sequencing: an alternative approach. 1992 ·PubMed ·R. Medori, (unknown), Pierluigi Gambetti	5
15	Dystrophin deficiency in young girls with sporadic myopathy and normal karyotype 1991 ·Neurology ·Carlo Minetti, Hai Won Chang, R. Medori, A. Prelle, Maurizio Moggio, Stanley D. Johnsen, E. Bonilla	23
16	The thalamus participates in the regulation of the sleep-waking cycle. A clinico-pathological study in fatal familial thalamic degeneration 1989 ·Electroencephalography and Clinical Neurophysiology ·Paolo Tinuper, P. Montagna, R. Medori, Pietro Cortelli, Marco Zucconi, Agostino Baruzzi, E Lugaresi	53
17	Experimental diabetic neuropathy: similar changes of slow axonal transport and axonal size in different animal models 1988 ·Journal of Neuroscience ·R. Medori, (unknown), L. Autilio‐Gambetti, Pierluigi Gambetti	76
18	LACK OF VEGETATIVE AND ENDOCRINE ORCADIAN RHYTHMS IN FATAL FAMILIAL THALAMIC DEGENERATION 1987 ·Clinical Endocrinology ·Alessandra Lugaresi, Agostino Baruzzi, E Cacciari, Pietro Cortelli, R. Medori, P. Montagna, Paolo Tinuper, Marco Zucconi, Ignazio Roiter, E Lugaresi	19
19	Gowers local panatrophy 1984 ·Neurological Sciences ·P. Montagna, R. Medori, Mario Zappia, R. Gallassi	2
20	A polygraphic study of one case of primary alveolar hypoventilation (Ondine's curse). 1984 ·PubMed ·(unknown), Fabio Cirignotta, Marco Zucconi, R Gerardi, R. Medori, E Lugaresi	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact